Jieqiong Cao

State Key Laboratory Of Bioactive Molecules And Druggability Assessment, Guangdong Province Key Laboratory Of Bioengineering Medicine
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Lian-Mei-Yin formula alleviates diet-induced hepatic steatosis by suppressing Yap1/FOXM1 pathway-dependent lipid synthesis.

Lian-Mei-Yin formula alleviates diet-induced hepatic steatosis by suppressing Yap1/FOXM1 pathway-dependent lipid synthesis.

Journal: Acta biochimica et biophysica Sinica

Published: March 22, 2024

Turning sublimed sulfur and bFGF into a nanocomposite to accelerate wound healing via co-activate FGFR and Hippo signaling pathway.

Turning sublimed sulfur and bFGF into a nanocomposite to accelerate wound healing via co-activate FGFR and Hippo signaling pathway.

Journal: Materials today. Bio

Published: March 08, 2024

Correction: Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist.

Correction: Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist.

Journal: Journal of nanobiotechnology

Published: February 18, 2024

Acesulfame potassium triggers inflammatory bowel disease via the inhibition of focal adhesion pathway.

Acesulfame potassium triggers inflammatory bowel disease via the inhibition of focal adhesion pathway.

Journal: Journal of hazardous materials

Published: December 26, 2023

Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis.

Inhibition of FGFR2 Signaling by Cynaroside Attenuates Liver Fibrosis.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 20, 2023

FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling.

FGFR4 and EZH2 inhibitors synergistically induce hepatocellular carcinoma apoptosis via repressing YAP signaling.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 27, 2023

Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist.

Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist.

Journal: Journal of nanobiotechnology

Published: December 28, 2022

Turning gray selenium and sublimed sulfur into a nanocomposite to accelerate tissue regeneration by isothermal recrystallization.

Turning gray selenium and sublimed sulfur into a nanocomposite to accelerate tissue regeneration by isothermal recrystallization.

Journal: Journal of nanobiotechnology

Published: September 19, 2022

Triclocarban triggers osteoarthritis via DNMT1-mediated epigenetic modification and suppression of COL2A in cartilage tissues.

Triclocarban triggers osteoarthritis via DNMT1-mediated epigenetic modification and suppression of COL2A in cartilage tissues.

Journal: Journal of hazardous materials

Published: June 22, 2022

Turning gray selenium into a nanoaccelerator of tissue regeneration by PEG modification.

Turning gray selenium into a nanoaccelerator of tissue regeneration by PEG modification.

Journal: Bioactive materials

Published: July 07, 2021

Development and Characterization of a Novel Peptide-Drug Conjugate with DM1 for Treatment of FGFR2-Positive Tumors.

Development and Characterization of a Novel Peptide-Drug Conjugate with DM1 for Treatment of FGFR2-Positive Tumors.

Journal: Biomedicines

Published: June 07, 2021

Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway.

Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway.

Journal: International journal of biological sciences

Published: May 10, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026